幹細胞製造市場規模、佔有率及成長分析（按產品、應用、最終用戶及地區分類）－2026-2033年產業預測

預計到 2024 年，幹細胞製造市場規模將達到 150.5 億美元，到 2025 年將達到 164.6 億美元，到 2033 年將達到 337.8 億美元，在預測期（2026-2033 年）內，複合年成長率為 9.4%。

幹細胞生產市場預計將迎來強勁成長，這主要得益於生產和儲存技術的進步，以及大眾對幹細胞衍生產品治療益處的認知不斷提高。多項研究表明，利用誘導多功能細胞（iPS細胞）、脂肪幹細胞（ASCs）和胚胎幹細胞（ESCs）等人類幹細胞進行治療，安全有效，可用於治療包括器官修復和先天性缺陷重組在內的多種疾病。隨著幹細胞庫生產和加工能力的提升，公私合作可望進一步擴大市場規模。在醫療環境不斷變化的背景下，隨著對幹細胞庫建設的深入研究和資金投入的增加，該行業有望實現顯著成長。

幹細胞製造市場促進因素

人們對再生醫學日益成長的興趣是推動幹細胞生產需求的主要因素。技術和方法的創新正在拓展幹細胞的潛在應用，創造個人化治療方案，並為慢性病管理提供解決方案。這種日益成長的興趣不僅推動了臨床和研究領域對幹細胞產品和服務的需求，也刺激了對幹細胞療法研發投入的增加。因此，幹細胞生產市場持續蓬勃發展，反映了這一充滿前景的醫學領域的顯著進步。

幹細胞製造市場限制因素

由於實驗室研究和臨床試驗中幹細胞的使用受到嚴格監管，幹細胞製造業面臨巨大的挑戰。這些監管壁壘延長了新產品的研發和核准流程，為該領域的企業帶來了不確定性。因此，企業可能被迫在這些限制條件下優先考慮創新，這可能導致投資減少和市場成長放緩。所以，儘管企業努力研發新的治療方法，但由於需要應對複雜的監管環境，幹細胞製造業的整體擴張可能會受到限制。

幹細胞製造市場趨勢

幹細胞生產市場正經歷一場變革性的趨勢，其特點是融合了3D生物列印和CRISPR基因編輯等尖端技術。這種融合使得幹細胞生產更加高效精準，提升了研發能力，並加速了治療方法的開發。隨著這些先進技術的不斷發展，它們有望為創新治療方法開闢新的途徑，並激發業內人士對幹細胞生產的興趣和投資。這些技術的綜效不僅革新了生產流程，也為再生醫學的重大突破鋪平了道路，最終促成了一個更充滿活力和穩健的市場格局。

目錄

介紹

• 調查目標
• 定義
• 市場覆蓋範圍

調查方法

• 資訊收集
• 二手和一手資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

前景
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 抑制因素
  • 任務
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 技術分析
• 供應鏈分析
• 價值鏈分析
• 定價分析
• 專利分析
• 客戶和購買標準分析

幹細胞製造市場：依產品分類

• 消耗品
  • 培養基
  • 其他消耗品
• 裝置
  • 生物反應器和培養箱
  • 細胞分選裝置
  • 其他設備
• 幹細胞株
  • 造血幹細胞
  • 間質幹細胞
  • 誘導性多功能幹細胞
  • 胚胎幹細胞
  • 神經幹細胞
  • 多功能成體祖細胞

幹細胞製造市場：依應用領域分類

• 研究用途
  • 生命科學研究
  • 藥物發現與開發
• 臨床應用
  • 異體幹細胞治療
  • 自體幹細胞治療
• 細胞和組織庫應用

按最終用戶分類的幹細胞製造市場

• 製藥和生物技術公司
• 學術、研究和受託研究機構
• 醫院及手術中心
• 細胞和組織庫
• 其他最終用戶

幹細胞製造市場：按地區分類的市場規模：

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市佔率（2025 年）

主要企業簡介

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Lonza Group
• Danaher Corporation
• Sartorius AG
• Becton, Dickinson and Company
• Eppendorf SE
• Corning Incorporated
• Bio-Rad Laboratories, Inc.
• Takara Bio Inc.
• Fujifilm Holdings Corporation
• Getinge AB
• Terumo Corporation
• Bio-Techne Corporation
• Himedia Laboratories Pvt. Ltd.
• Stemcell Technologies, Inc.
• Miltenyi Biotec GmbH
• Promocell
• Anterogen Co. Ltd.
• Cellgenix GmbH
• Pluristem Therapeutics Inc.
• Daiichi Sankyo
• Organogenesis Holdings Inc.
• Vericel Corp.
• American Cryostem Corp.

Stem Cell Manufacturing Market size was valued at USD 15.05 Billion in 2024 and is poised to grow from USD 16.46 Billion in 2025 to USD 33.78 Billion by 2033, growing at a CAGR of 9.4% during the forecast period (2026-2033).

The stem cell manufacturing market is poised for robust growth, fueled by advancements in manufacturing and storage technologies and increased public awareness of the therapeutic benefits of stem cell-derived products. Evidence from various studies highlights the safety and efficacy of stem cell therapy for treating a range of diseases, utilizing human stem cell types like induced pluripotent stem cells (iPSCs), adipose-derived stem cells (ASCs), and embryonic stem cells (ESCs) for organ repair and congenital defect reconstruction. Collaboration among public and private sectors is expected to enhance production and processing capabilities within stem cell banks, further driving market expansion. As research intensifies and funding for stem cell bank establishment increases, the segment anticipates significant growth amid an evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stem Cell Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stem Cell Manufacturing Market Segments Analysis

Global Stem Cell Manufacturing Market is segmented by Product, Application, End User and Region. Based on Product, the market is segmented into Consumables (Culture Media, Other Consumables), Instruments (Bioreactors & Incubators, Cell Sorters, Other Instruments), Stem Cell Lines (Hematopoietic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Neural Stem Cells, Multipotent Adult Progenitor Stem Cells). Based on Application, the market is segmented into Research Applications (Life Science Research, Drug Discovery & Development), Clinical Applications (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell & Tissue Banking Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories, and Contract Research Organizations, Hospitals & Surgical Centers, Cell & Tissue Banks, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Stem Cell Manufacturing Market

The growing focus on regenerative medicine is a key factor propelling the demand for stem cell manufacturing. Innovations in technology and methodologies are expanding the potential applications of stem cells, enabling the creation of personalized treatments and offering solutions for chronic disease management. This surge in interest not only boosts the need for stem cell products and services within clinical and research environments but also encourages increased investment in the research and development of stem cell therapies. As a result, the marketplace for stem cell manufacturing continues to flourish, reflecting the significant advancements in this promising field of medicine.

Restraints in the Stem Cell Manufacturing Market

The stem cell manufacturing industry faces significant challenges due to stringent regulations that govern the use of stem cells in laboratory research and clinical trials. These regulatory hurdles can prolong the development and approval processes for new products, creating an environment of uncertainty for companies in the field. As a result, businesses may prioritize creativity and innovation within these constraints, which could lead to reduced investments and slower market growth. Consequently, the overall expansion of the stem cell manufacturing sector may be limited as companies navigate these complex regulatory landscapes while striving to bring new therapies to fruition.

Market Trends of the Stem Cell Manufacturing Market

The Stem Cell Manufacturing market is witnessing a transformative trend characterized by the integration of cutting-edge technologies such as 3D bioprinting and CRISPR gene editing. This convergence is facilitating more efficient and precise stem cell production, enhancing research capabilities and accelerating therapeutic developments. As these advanced technologies continue to evolve, they promise to unlock new avenues for innovative therapies, driving increased interest and investment within the sector. The synergy of these technologies is not only revolutionizing manufacturing processes but also paving the way for significant breakthroughs in regenerative medicine, ultimately contributing to a more dynamic and robust market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Technology Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis

Stem Cell Manufacturing Market, By Product

• Market Overview
• Consumables
  • Culture Media
  • Other Consumables
• Instruments
  • Bioreactors & Incubators
  • Cell Sorters
  • Other Instruments
• Stem Cell Lines
  • Hematopoietic Stem Cells
  • Mesenchymal Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
  • Neural Stem Cells
  • Multipotent Adult Progenitor Stem Cells

Stem Cell Manufacturing Market, By Application

• Market Overview
• Research Applications
  • Life Science Research
  • Drug Discovery & Development
• Clinical Applications
  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy
• Cell & Tissue Banking Applications

Stem Cell Manufacturing Market, By End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic Institutes, Research Laboratories, And Contract Research Organizations
• Hospitals & Surgical Centers
• Cell & Tissue Banks
• Other End Users

Stem Cell Manufacturing Market Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himedia Laboratories Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promocell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anterogen Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellgenix GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pluristem Therapeutics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Cryostem Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments